Source: IMAGE SOURCE: GETTY IMAGES

Why all the optimism about travel in the midst of a pandemic – and a pandemic-induced recession? Investors are starting to look forward to the day when a cure for coronavirus will be found, this recession will be over, and business will eventually return to normal. Reinforcing that belief, biotech Moderna Inc. this morning released "interim Phase 1 data" on a vaccine it has under development – "mRNA-1273" – which suggests the vaccine "was generally safe and well tolerated" in the clinical trial, "elicits an immune response of the magnitude caused by natural infection" in humans, and "provided full protection against viral replication in the lungs in a mouse challenge model."

Read the full article at The Motley Fool